Shakti Shukla

Shakti Shukla

University of Technology

H-index: 32

Asia-India

About Shakti Shukla

Shakti Shukla, With an exceptional h-index of 32 and a recent h-index of 27 (since 2020), a distinguished researcher at University of Technology, specializes in the field of Respiratory infections, Microbial adhesins, COPD, Asthma, Microbiome.

His recent articles reflect a diverse array of research interests and contributions to the field:

Faecal microbial transfer and complex carbohydrates mediate protection against COPD

Tackling the cytokine storm using advanced drug delivery in allergic airway disease

Lipid Profiling Reveals Key Lipid Mediators in Cigarette Smoke-induced Experimental COPD

Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease

Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases

Understanding the pathogenesis of occupational coal and silica dust-associated lung disease

Correction to: Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases

Broadening concepts of core pathobiology in various aspects of COPD development

Shakti Shukla Information

University

Position

NSW Australia

Citations(all)

3879

Citations(since 2020)

3513

Cited By

1353

hIndex(all)

32

hIndex(since 2020)

27

i10Index(all)

55

i10Index(since 2020)

53

Email

University Profile Page

University of Technology

Google Scholar

View Google Scholar Profile

Shakti Shukla Skills & Research Interests

Respiratory infections

Microbial adhesins

COPD

Asthma

Microbiome

Top articles of Shakti Shukla

Title

Journal

Author(s)

Publication Date

Faecal microbial transfer and complex carbohydrates mediate protection against COPD

Gut

Kurtis F Budden

Shakti D Shukla

Kate L Bowerman

Annalicia Vaughan

Shaan L Gellatly

...

2024/2/8

Tackling the cytokine storm using advanced drug delivery in allergic airway disease

Vyoma K Patel

Sukriti Vishwas

Rajan Kumar

Gabriele De Rubis

Shakti D Shukla

...

2023/3/20

Lipid Profiling Reveals Key Lipid Mediators in Cigarette Smoke-induced Experimental COPD

SF Rehman

D Fuchs

KF Budden

A Quaranta

SD Shukla

...

2023/5

Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease

Keshav Raj Paudel

Meenu Mehta

Shakti Dhar Shukla

Nisha Panth

Dinesh Kumar Chellappan

...

2022/10

Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases

Daljeet Singh Dhanjal

Parvarish Sharma

Meenu Mehta

Murtaza M Tambuwala

Parteek Prasher

...

2022/2

Understanding the pathogenesis of occupational coal and silica dust-associated lung disease

Kanth Swaroop Vanka

Shakti Shukla

Henry M Gomez

Carole James

Thava Palanisami

...

2022/9/30

Correction to: Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases

Inflammopharmacology

Shakti D Shukla

Madhur D Shastri

Swaroop K Vanka

Niraj Kumar Jha

Harish Dureja

...

2022

Broadening concepts of core pathobiology in various aspects of COPD development

European Respiratory Journal

Eugene H Walters

Shakti Shukla

Chis Ward

2022/12/1

Treatment of chronic airway diseases using nutraceuticals: Mechanistic insight

Venkata Sita Rama Raju Allam

Dinesh Kumar Chellappan

Niraj Kumar Jha

Madhur D Shastri

Gaurav Gupta

...

2022/9/22

An Introduction to Respiratory Diseases and an Emerging Need for Efficient Drug Delivery Systems

Krishna Sunkara

Meenu Mehta

Saurabh Satija

Daljeet Singh Dhanjal

Parvarish Sharma

...

2022/3/24

Nutraceuticals and COVID‐19: A mechanistic approach toward attenuating the disease complications

Journal of Food Biochemistry

Keshav Raj Paudel

Vyoma Patel

Sukriti Vishwas

Saurabh Gupta

Sumit Sharma

...

2022/10/14

Association between dietary fibre, microbial metabolites and airway obstruction in COPD patients and murine models

K Budden

SF Rehman

S Shukla

K Bowerman

C Donovan

...

2022/9/4

Soluble epoxide hydrolase inhibition alleviates inflammation in cigarette smoke-induced experimental COPD irrespective of dietary fat content

SF Rehman

KF Budden

A Quaranta

D Fuchs

SD Shukla

...

2022/9/4

Exploring the role of antibiotics and steroids in managing respiratory diseases

Dinesh K Chellappan

Parteek Prasher

Shakti D Shukla

Tong W Yee

Tiong K Kah

...

2022/10

Toll-like receptors, innate immune system, and lung diseases: a vital trilateral association

EXCLI journal

Vyoma K Patel

Keshav R Paudel

Shakti D Shukla

Gang Liu

Brian G Oliver

...

2022

Silicosis: Pathogenesis and utility of animal models of disease.

Allergy

Eugene Haydn Walters

Shakti D Shukla

2021/10/1

Targeting Cellular Signalling Pathways in Lung Diseases

Kamal Dua

Raimar Löbenberg

Ângela Cristina Malheiros Luzo

Shakti Shukla

Saurabh Satija

2021/7/28

Targeting LIN28: a new hope in prostate cancer theranostics

Garima Shrivastava

Alaa AA Aljabali

Seyed Hossein Shahcheraghi

Marzieh Lotfi

Madhur D Shastri

...

2021/6

COVID-19 in underlying COPD Patients

EXCLI Journal

Krishna Sunkara

Venkata Allam

Shakti Shukla

Dinesh Kumar Chellappan

Gaurav Gupta

...

2021/2/5

Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases

Meenu Mehta

Keshav Raj Paudel

Shakti Dhar Shukla

Venkata Sita Rama Raju Allam

Vinod Kumar Kannaujiya

...

2021/9/10

See List of Professors in Shakti Shukla University(University of Technology)

Co-Authors

H-index: 59
Chris Ward

Chris Ward

Newcastle University

H-index: 51
Dinesh Kumar Chellappan

Dinesh Kumar Chellappan

International Medical University

H-index: 43
Sachin Kumar Singh

Sachin Kumar Singh

Lovely Professional University

H-index: 31
Paudel KR

Paudel KR

University of Technology & Management

H-index: 31
Ronan O'Toole

Ronan O'Toole

La Trobe University

academic-engine